Controlled Clinical Trial of Clofazimine in Untreated Lepromatous Leprosy
- 27 November 1971
- Vol. 4 (5786) , 514-516
- https://doi.org/10.1136/bmj.4.5786.514
Abstract
A comparison of clofazimine and dapsone in the management of untreated lepromatous leprosy showed no significant differences between the two drugs in terms of morphological and bacterial indices. The incidence of erythema nodosum leprosum was similar in the two groups. Since dapsone is cheaper than clofazimine it remains the drug of choice for the routine management of untreated lepromatous leprosy.Keywords
This publication has 6 references indexed in Scilit:
- Double-Blind Controlled Clinical Trial of Clofazimine in Reactive Phases of Leprotamous LeprosyBMJ, 1970
- Chemotherapeutic trials in leprosy. 3. Pilot trial of a riminophenazine derivative. B.663, in the treatment of lepromatous leprosy.1967
- Leprosy research at the National Institutes of Health: experience with B.663 in the treatment of leprosy.1965
- Treatment of Leprosy with B 663 Appraisal of the Pilot Trial after three yearsLeprosy Review, 1965
- "B 663" IN THE TREATMENT OF LEPROSY - Preliminary Report of a Pilot TrialLeprosy Review, 1962
- Public Health Weekly Reports for NOVEMBER 26, 1943.1943